Next Article in Journal
Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management
Next Article in Special Issue
A Methodological Framework for Evaluating the Evidence for Complementary and Alternative Medicine (CAM) for Cancer
Previous Article in Journal
Lung Cancer Susceptibility and hOGG1 Ser326Cys Polymorphism: A Meta-Analysis
Open AccessReview

NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells

IBB-Institute for Biotechnology and Bioengineering, Centre for Molecular and Structural Biomedicine (CBME), University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
*
Author to whom correspondence should be addressed.
Cancers 2010, 2(4), 1838-1860; https://doi.org/10.3390/cancers2041838
Received: 15 October 2010 / Revised: 3 November 2010 / Accepted: 4 November 2010 / Published: 5 November 2010
(This article belongs to the Special Issue Cancer Diagnosis and Targeted Therapy)
Two main NF-κB signaling pathways, canonical and noncanonical, performing distinct functions in organisms have been characterized. Identification of mutations in genes encoding components of these NF-κB signaling pathways in lymphoid malignancies confirmed their key role in leukemogenesis. T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of thymocytes that despite significant therapeutic advances can still be fatal. Although mutations in NF-κB genes have not been reported in T-ALL, NF-κB constitutive activation in human T-ALL and in acute T-cell leukemia mouse models has been observed. Although these studies revealed activation of members of both canonical and noncanonical NF-κB pathways in acute T-cell leukemia, only inhibition of canonical NF-κB signaling was shown to impair leukemic T cell growth. Besides playing an important pro-oncogenic role in leukemic T cells, NF-κB signaling also appears to modulate T-cell leukemogenesis through its action in microenvironmental stromal cells. This article reviews recent data on the role of these transcription factors in T-ALL and pinpoints further research crucial to determine the value of NF-κB inhibition as a means to treat T-ALL. View Full-Text
Keywords: NF-κB; signaling; T cell; leukemia; lymphoma; NOTCH1; microenvironment NF-κB; signaling; T cell; leukemia; lymphoma; NOTCH1; microenvironment
Show Figures

Figure 1

MDPI and ACS Style

Dos Santos, N.R.; Ghezzo, M.N.; Da Silva, R.C.; Fernandes, M.T. NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells. Cancers 2010, 2, 1838-1860.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop